top of page

Mwandishi:

Mhariri:

Imeboreshwa:

ULY CLINIC

© Hairuhusiwi kukopi bila kibali cha ULYCLINIC

ULY CLINIC

28 Februari 2026, 14:40:16

Image-empty-state.png
Image-empty-state.png
Image-empty-state.png
Image-empty-state.png

Sexual dysfunction

23 Novemba 2020, 12:27:47

Sexual dysfunction refers to a persistent disturbance in sexual desire, arousal, orgasm, or pain associated with sexual activity that causes significant personal distress or interpersonal difficulty. It may affect both males and females and can arise from psychological, medical, hormonal, neurological, relational, or medication-related causes.


Sexual dysfunction is common but frequently underreported due to stigma, cultural beliefs, and embarrassment. Proper evaluation is essential since it may indicate underlying systemic or psychiatric illness.


Classification

Sexual dysfunction is broadly categorized into:


Male Sexual Dysfunction

  • Erectile dysfunction

  • Premature ejaculation

  • Delayed ejaculation

  • Hypoactive sexual desire disorder


Female Sexual Dysfunction

  • Female sexual interest/arousal disorder

  • Orgasmic disorder

  • Genito-pelvic pain/penetration disorder

  • Dyspareunia

  • Vaginal dryness


Risk Factors


Medical Factors

  • Diabetes mellitus

  • Cardiovascular disease

  • Hypertension

  • Chronic kidney disease

  • Hormonal disorders (hypogonadism, thyroid disease)

  • Neurological disorders

  • Chronic pain conditions


Psychological Factors

  • Depression

  • Anxiety disorders

  • Stress

  • Relationship conflict

  • History of sexual trauma


Lifestyle Factors

  • Smoking

  • Alcohol abuse

  • Substance misuse

  • Physical inactivity

  • Obesity


Medication-Related Causes

  • Antidepressants (especially SSRIs)

  • Antipsychotics

  • Antihypertensives

  • Hormonal therapies

  • Sedatives


Signs and Symptoms


Desire Disorders

  • Reduced libido

  • Lack of sexual thoughts or fantasies


Arousal Disorders

  • Erectile difficulty

  • Reduced vaginal lubrication

  • Difficulty maintaining arousal


Orgasmic Disorders

  • Delayed orgasm

  • Absence of orgasm

  • Reduced orgasm intensity


Sexual Pain Disorders

  • Pain during intercourse

  • Fear or avoidance of penetration


Associated Features

  • Relationship distress

  • Performance anxiety

  • Emotional withdrawal


Diagnostic Criteria

Diagnosis is clinical and requires:

  • Persistent or recurrent sexual difficulty

  • Duration ≥ 6 months

  • Significant personal distress

  • Not better explained by severe psychiatric illness, substance use, or medical emergency


Assessment should include:

  • Sexual history

  • Medical history

  • Medication review

  • Psychosocial evaluation

  • Relationship assessment


Investigations

Investigations aim to identify reversible causes.


Laboratory Tests

  • Fasting blood glucose / HbA1c

  • Lipid profile

  • Serum testosterone (morning sample in males)

  • Thyroid function tests

  • Prolactin level

  • Renal and liver function tests


Additional Evaluation

  • Cardiovascular risk assessment

  • Depression and anxiety screening

  • Pelvic examination (female)

  • Genital examination (male)

Specialized testing when indicated:

  • Penile Doppler ultrasound

  • Nocturnal penile tumescence testing


Management

Management requires a biopsychosocial approach.


Non-Pharmacological Management


Education and Counseling

  • Provide reassurance and normalize discussion

  • Address myths and cultural misconceptions

  • Sexual health education


Psychotherapy

  • Cognitive Behavioural Therapy (CBT)

  • Sex therapy

  • Couples therapy

  • Anxiety and depression management


Lifestyle Modification

  • Smoking cessation

  • Reduce alcohol intake

  • Regular physical exercise

  • Weight reduction

  • Adequate sleep


Medication Review

  • Consider discontinuation or substitution of drugs causing dysfunction where possible.


Pharmacological Management


General Principles

  • Treat the underlying medical or psychiatric condition first.

  • Pharmacotherapy should be individualized.


Erectile Dysfunction (Selected Patients)

Phosphodiesterase-5 inhibitors may be used under medical supervision:

  • Sildenafil

  • Tadalafil

  • Vardenafil

Caution

  • May cause severe hypotension when combined with nitrates.

  • Cardiovascular assessment is required before prescription.

  • Self-medication is strongly discouraged.


Hormonal Therapy

Indicated only when laboratory-confirmed deficiency exists:

  • Testosterone replacement therapy (hypogonadism)


Female Sexual Dysfunction

Management may include:

  • Vaginal lubricants or moisturizers

  • Local estrogen therapy (post-menopausal women)


Referral Indications

Refer to specialist when:

  • Persistent dysfunction despite treatment

  • Suspected endocrine disorder

  • Complex psychiatric illness

  • Severe relationship conflict

  • Suspected anatomical abnormality


Referral options:

  • Urologist

  • Gynecologist

  • Psychiatrist

  • Endocrinologist

  • Certified sex therapist


Complications

Untreated sexual dysfunction may lead to:

  • Relationship breakdown

  • Depression and anxiety

  • Reduced quality of life

  • Low self-esteem

  • Treatment non-adherence in chronic disease patients


Prevention

  • Early treatment of chronic diseases

  • Mental health support

  • Healthy lifestyle promotion

  • Rational prescribing practices

  • Open patient–clinician communication

  • Routine sexual health screening in chronic illness


Patient Education

Patients should be advised that:

  • Sexual dysfunction is common and treatable.

  • Many cases are reversible once underlying causes are managed.

  • Avoid unprescribed sexual enhancement medications.

  • Psychological wellbeing significantly affects sexual performance.

  • Early consultation improves outcomes.


Prognosis

Outcome depends on the underlying cause. Psychogenic and medication-related dysfunctions generally have good prognosis when appropriately managed. Chronic vascular or neurological causes may require long-term treatment.


References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). Washington DC: APA; 2022.

  2. World Health Organization. ICD-11 Classification of Sexual Health Disorders. Geneva: WHO; 2019.

  3. Burnett AL, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641.

  4. McCabe MP, et al. Definitions of sexual dysfunctions in women and men. J Sex Med. 2016;13(2):135-143.

  5. Basson R. Female sexual dysfunction. Lancet. 2015;385(9965):2526-2534.

  6. Clayton AH, et al. Sexual dysfunction related to psychiatric medications. CNS Drugs. 2014;28(5):421-438.

  7. NICE Guideline NG23. Sexual health and wellbeing. London: National Institute for Health and Care Excellence; 2020.

  8. Shifren JL, Monz BU. Sexual problems and distress in women. Obstet Gynecol. 2008;112(5):970-978.


Imeandikwa:

bottom of page